{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:35:43Z","timestamp":1778052943786,"version":"3.51.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In the era of antiretroviral therapy (ART), Hodgkin Lymphoma (HL) is a common non-AIDS-defining cancer with increasing incidence in people with human immunodeficiency virus (PWH). Through review of these cases, we identify clinical patterns such as declining CD4 count despite ART, hyperbilirubinemia and recurrent fever, which preceded diagnosis. Identifying these important signs and symptoms may lead to earlier diagnosis and initiation of therapy. Fulminant hepatic failure limits the ability to give standard of care chemotherapy, likely jeopardizing outcomes in this patient population. Alternative bridging therapies should be considered until hepatic function improves.<\/jats:p>","DOI":"10.1093\/ofid\/ofad273","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T11:51:27Z","timestamp":1688385087000},"source":"Crossref","is-referenced-by-count":2,"title":["Fulminant Hepatic Failure as the Initial Presentation of Hodgkin Lymphoma in 4 Patients With Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-0648","authenticated-orcid":false,"given":"Mary","family":"Cook","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Maryland Medical Center , Baltimore, Maryland , USA"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Maryland Medical Center , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie Y","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Maryland Medical Center , Baltimore, Maryland , USA"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Riedel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Maryland Medical Center , Baltimore, Maryland , USA"},{"name":"Division of Infectious Disease, University of Maryland Medical Center , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"2023073108372437100_ofad273-B1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2023073108372437100_ofad273-B2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals","volume":"52","author":"Shiels","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023073108372437100_ofad273-B3","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"2023073108372437100_ofad273-B4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"2023073108372437100_ofad273-B5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/157016210790442704","article-title":"Hodgkin lymphoma in HIV positive patients","volume":"8","author":"Mounier","year":"2010","journal-title":"Curr HIV Res"},{"key":"2023073108372437100_ofad273-B6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/apc.2012.0424","article-title":"Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy","volume":"27","author":"Gotti","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"2023073108372437100_ofad273-B7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002770050186","article-title":"Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients","volume":"72","author":"Cervantes","year":"1996","journal-title":"Ann Hematol"},{"key":"2023073108372437100_ofad273-B8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00042737-199909000-00019","article-title":"Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease","volume":"11","author":"Dourakis","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2023073108372437100_ofad273-B9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3816\/CLM.2001.n.018","article-title":"Hepatic failure as the presenting manifestation of malignant lymphoma","volume":"2","author":"Thompson","year":"2001","journal-title":"Clin Lymphoma"},{"key":"2023073108372437100_ofad273-B10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0140-6736(06)68432-8","article-title":"Hodgkin's lymphoma: an obscure cause of cholestasis","volume":"367","author":"Castel","year":"2006","journal-title":"Lancet"},{"key":"2023073108372437100_ofad273-B11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1872-034X.2008.00358.x","article-title":"Primary hepatic presentation of Hodgkin's lymphoma: a case report","volume":"38","author":"Yokomori","year":"2008","journal-title":"Hepatol Res"},{"key":"2023073108372437100_ofad273-B12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3109\/10428191003699571","article-title":"Hodgkin lymphoma and fulminant hepatic failure","volume":"51","author":"Hong","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"2023073108372437100_ofad273-B13","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3748\/wjg.v16.i35.4491","article-title":"Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma","volume":"16","author":"Mrzljak","year":"2010","journal-title":"World J Gastroenterol"},{"key":"2023073108372437100_ofad273-B14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00004836-199401000-00023","article-title":"Hepatic failure from Hodgkin's disease in a patient with HIV infection","volume":"18","author":"Weiner","year":"1994","journal-title":"J Clin Gastroenterol"},{"key":"2023073108372437100_ofad273-B15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1055-9965.EPI-13-0865","article-title":"Prevalence of HIV infection among U.S. Hodgkin lymphoma cases","volume":"23","author":"Shiels","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2023073108372437100_ofad273-B16","doi-asserted-by":"crossref","first-page":"507257","DOI":"10.1155\/2012\/507257","article-title":"HIV-Associated Hodgkin's lymphoma: prognosis and therapy in the era of cART","volume":"2012","author":"Jacobson","year":"2012","journal-title":"Adv Hematol"},{"key":"2023073108372437100_ofad273-B17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2217\/bmm.15.13","article-title":"The role of the tumor microenvironment in HIV-associated lymphomas","volume":"9","author":"Taylor","year":"2015","journal-title":"Biomark Med"},{"key":"2023073108372437100_ofad273-B18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection","volume":"27","author":"Powles","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023073108372437100_ofad273-B19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era","volume":"105","author":"Gopal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2023073108372437100_ofad273-B20","first-page":"e2009032","article-title":"EBV and HIV-related lymphoma","volume":"1","author":"Bibas","year":"2009","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2023073108372437100_ofad273-B21","first-page":"e2009013","article-title":"EBV in Hodgkin lymphoma","volume":"1","author":"Massini","year":"2009","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2023073108372437100_ofad273-B22","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1182\/blood-2010-08-301531","article-title":"HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes","volume":"117","author":"Bohlius","year":"2011","journal-title":"Blood"},{"key":"2023073108372437100_ofad273-B23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/QAD.0000000000000980","article-title":"CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma","volume":"30","author":"Hoffmann","year":"2016","journal-title":"AIDS"},{"key":"2023073108372437100_ofad273-B24","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaoncol.2015.2975","article-title":"Lymphadenopathy and jaundice","volume":"1","author":"Law","year":"2015","journal-title":"JAMA Oncol"},{"key":"2023073108372437100_ofad273-B25"},{"key":"2023073108372437100_ofad273-B26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjh.17073","article-title":"Results of a UK National Cancer Research Institute phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)","volume":"193","author":"Gibb","year":"2021","journal-title":"Br J Haematol"},{"key":"2023073108372437100_ofad273-B27","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.clml.2015.11.015","article-title":"Single-agent brentuximab as bridging therapy for Hodgkin lymphoma patients with hepatic impairment","volume":"16","author":"Gupta","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/7\/ofad273\/51009571\/ofad273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/7\/ofad273\/51009571\/ofad273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T08:39:16Z","timestamp":1690792756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad273\/7217019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad273","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,7,1]]},"article-number":"ofad273"}}